The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

CVS will shut down more than 270 stores in 2025 as part of a restructuring plan. Here's what it means for pharmacy access and your local prescription options.

CVS and Walgreens do not share how many Medicare Part D prescriptions they fill. Now, Amazon Pharmacy is adding features aimed at seniors to break into the fast-growing Medicare market, as more ...

Eli Lilly’s stock wobbled after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda will become the preferred options ...

Patients taking Zepbound will be able to switch to Wegovy if the Lilly drug is excluded from their coverage, Whitrap said. CVS Health also said Thursday that it will start selling Wegovy at a ...

CVS Health's Q1 earnings call will spotlight Aetna's performance, new CFO Brian Newman's impact, and the company's strategy amid industry challenges. Providence Business First.

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...